Arnhold LLC’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,899
Closed -$2.31M 117
2026
Q1
$2.31M Hold
7,899
0.17% 66
2025
Q4
$2.77M Hold
7,899
0.21% 58
2025
Q3
$2.55M Hold
7,899
0.21% 59
2025
Q2
$3.07M Hold
7,899
0.28% 53
2025
Q1
$3.44M Hold
7,899
0.35% 47
2024
Q4
$2.91M Buy
+7,899
New +$3.31M 0.29% 52

Other funds holding ELV

Arnhold LLC's ELV Position: Q2 2026 in Review

Arnhold LLC sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 7,899 shares — an estimated $2.31M sold.

Arnhold LLC first reported a position in ELV in Q4 2024 and held it in 6 quarters. The position peaked at $3.44M in Q1 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Arnhold LLC reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Arnhold LLC sold 7,899 Elevance Health shares in Q2 2026, an estimated $2.31M.
  • Arnhold LLC first reported a position in Elevance Health in Q4 2024 and held it in 6 quarters.
  • Arnhold LLC's Elevance Health position peaked at $3.44M in Q1 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Arnhold LLC's 13F filing for Q2 2026, filed 27 Jul 2026.